Daniel Martin Simadibrata, MD

PGY-2 Internal Medicine Resident @mhmedres @cwru | 🇮🇩 | Clinical Trials @Oxford_NDPH

[Digestive Disease Week @DDWMeeting]

"Shifts in use of #GERD surgical procedures underscore advancements in procedures and evolving patient preferences," says @DM_Simadibrata of @MHMedRes at #DDW2025.

To get the full scoop, click here: https://t.co/NZGQRKa1wl

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@vermaanjul08 Congratulations Anjul, great work!

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@Pragyatf @RochesterEpi @HRS_O2Journal @TheRhythmDoc @cha_yongmei @abhishek_mbbs @drvrvaidya @RahulMishraMBBS Great work!

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@nicolasgisell Awesome news!

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@_AnyaHall Congrats Anya! Well deserved man

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@CandrikaDini Massive congratulations! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@DrAnjaliR_ Congratulations! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@Nasrinnikravan @TheNRMP Congratulations 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@ManikGIMD Congratulations Manik!! Very well deserved!

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

Key takeaways from our study:

👉 Mild Erosive Esophagitis (LA Grade A/B) ➡ PPI/Lansoprazole preferred

👉 Severe Erosive Esophagitis (LA Grade C/D) ➡ Vonoprazan preferred

Grateful for the mentorship and guidance! @RonnieFass @lesmana_elvira

#GITwitter

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

#Vonoprazan is NOT SUPERIOR to #Lansoprazole for healing of Mild #ErosiveEsophagitis (LA Grade A/B)

Our study in @JGHofficial showed that Vonoprazan is only superior to Lansoprazole for healing of severe EE (LA Grade C/D)

Free Full Text: https://t.co/FEMyl1NUFD

#GITwitter

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@Pragyatf Congratulations Pragyat! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@GloriaSong88 Congratulations on the great news, Gloria!

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

Our SRMA in @JGHofficial showed that #Vonoprazan has high efficacy in healing & maintenance of PPI-resistant EE and moderate efficacy for improving FSSG score in PPI-resistant #GERD

Free Full-Text: https://t.co/92lUcGoWfK

Very grateful for the mentorship @RonnieFass! #GITwitter

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@CandrikaDini @JACCJournals @bbikdeli @AntoineBejjani_ @BrighamResearch Congratulations! A very impressive work! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@aldoferly Congrats Ko! Semoga lancar dan sukses terus di fase hidup selanjutnya 🎉

[Neurogastro & Motil @NGMJournal]

@maura_corsetti @IBS_Maastricht @DrCJBlack @AndreaShin_GI @mpj61 @ANMSociety @esnm_eu @SSrinivasanMD @karagm2009 @LindaNguyenMD @DrvanTilburg @BMoshiree @DharJahnvi @ThisIsButt @Pierfra_Visaggi @VorkLisa @Rajan___Singh ✅Diagnostic accuracy of #GastroesophagealRefluxDisease questionnaire for gastroesophageal reflux disease: A systematic review and meta-analysis🔥🔥🔥🔥🔥
👉 https://t.co/owceuXdsKU
✔️https://t.co/PLzEKexR1B
@ANMSociety @esnm_eu
#GITwitter #MedTwitter #ScienceTwitter

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@Montalvan214 Congratulations!! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@seanpattyp Congratulations!! 🎉

[Daniel Martin Simadibrata, MD @DM_Simadibrata]

@MouhandMD Congratulations @MouhandMD!! Excited for you 🎉